The class action lawsuit against Edwards Lifesciences for alleged securities fraud is likely to negatively impact the stock price in the short term. Legal issues can lead to uncertainty and reduced investor confidence, which often results in stock price declines. The high relevance and importance scores reflect the direct impact of the lawsuit on the company.